Invesco Ltd. Acquires Shares of 200,000 Kestra Medical Technologies, Ltd. $KMTS

Key Points

• Invesco Ltd. acquired 200,000 shares of Kestra Medical Technologies, valued at approximately $4.98 million, during the first quarter.
• Several other large investors also increased their stakes in Kestra Medical Technologies, with Brown Advisory Inc. leading with a new investment of $13.72 million.
• Wells Fargo & Company lowered their price target on Kestra Medical Technologies from $28.00 to $27.00, maintaining an "overweight" rating, while the stock currently holds an average rating of "Moderate Buy."

Invesco Ltd. purchased a new stake in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 200,000 shares of the company's stock, valued at approximately $4,984,000. Invesco Ltd. owned 0.39% of Kestra Medical Technologies as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Caas Capital Management LP acquired a new position in shares of Kestra Medical Technologies during the 1st quarter valued at $1,470,000. Jennison Associates LLC acquired a new stake in Kestra Medical Technologies in the first quarter worth $1,869,000. TD Asset Management Inc bought a new stake in Kestra Medical Technologies in the first quarter valued at $2,306,000. Federated Hermes Inc. acquired a new position in shares of Kestra Medical Technologies during the first quarter valued at about $9,968,000. Finally, Brown Advisory Inc. bought a new position in shares of Kestra Medical Technologies during the 1st quarter worth about $13,716,000.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company dropped their price target on Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating on the stock in a research note on Thursday, July 17th. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $27.33.

Kestra Medical Technologies Trading Down 8.9%

NASDAQ KMTS traded down $1.57 on Friday, reaching $16.14. The company had a trading volume of 296,072 shares, compared to its average volume of 202,564. The business has a fifty day moving average price of $16.23. Kestra Medical Technologies, Ltd. has a 52-week low of $13.25 and a 52-week high of $26.15. The company has a current ratio of 6.72, a quick ratio of 6.72 and a debt-to-equity ratio of 0.20.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.